{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:59:35Z","timestamp":1792202375133,"version":"4.4.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T00:00:00Z","timestamp":1528761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["106698\/Z\/14\/Z"],"award-info":[{"award-number":["106698\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1181807"],"award-info":[{"award-number":["OPP1181807"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1099191"],"award-info":[{"award-number":["OPP1099191"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002579","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T13:22:54Z","timestamp":1528809774000},"page":"e1002579","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":60,"title":["Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7213-4559","authenticated-orcid":true,"given":"Frank","family":"Kloprogge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3433-6106","authenticated-orcid":true,"given":"Lesley","family":"Workman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Borrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamadou","family":"T\u00e9k\u00e9t\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Lef\u00e8vre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Piola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Ursing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poul Erik","family":"Kofoed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"M\u00e5rtensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Billy","family":"Ngasala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Bj\u00f6rkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9122-8294","authenticated-orcid":true,"given":"Michael","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Friberg Hietala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Aweeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Mwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M. E.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harin","family":"Karunajeewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8276-6784","authenticated-orcid":true,"given":"Sam","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9030-5382","authenticated-orcid":true,"given":"Francesco","family":"Checchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3000-6185","authenticated-orcid":true,"given":"Carole","family":"Fogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul N.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayfong","family":"Mayxay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Deloron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1629-1194","authenticated-orcid":true,"given":"Jean Fran\u00e7ois","family":"Faucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7951-0745","authenticated-orcid":true,"given":"Fran\u00e7ois","family":"Nosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7620-4822","authenticated-orcid":true,"given":"Elizabeth A.","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1621-3257","authenticated-orcid":true,"given":"Rose","family":"McGready","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"van Vugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4201-5473","authenticated-orcid":true,"given":"Stephane","family":"Proux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2000-2874","authenticated-orcid":true,"given":"Ric N.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntra","family":"Karbwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farkad","family":"Ezzet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Bakshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasia","family":"Stepniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1897-1978","authenticated-orcid":true,"given":"Nicholas J.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6008-2963","authenticated-orcid":true,"given":"Philippe J.","family":"Guerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen I.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4566-4030","authenticated-orcid":true,"given":"Joel","family":"Tarning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,6,12]]},"reference":[{"key":"ref1","year":"2016"},{"key":"ref2","year":"2015"},{"key":"ref3","year":"2014"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00228-006-0199-7","article-title":"The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria","volume":"62","author":"R McGready","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1038\/psp.2013.59","article-title":"Population pharmacokinetics of lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Uganda","volume":"2","author":"F Kloprogge","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1128\/AAC.00195-09","article-title":"Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated <italic>Plasmodium falciparum<\/italic> malaria","volume":"53","author":"J Tarning","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/1475-2875-11-293","article-title":"Population pharmacokinetics of artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda","volume":"11","author":"J Tarning","year":"2012","journal-title":"Malar J"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1128\/AAC.00683-13","article-title":"Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine and quinine in pregnant women with uncomplicated falciparum malaria in Uganda","volume":"57","author":"J Tarning","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1128\/AAC.05136-11","article-title":"Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria","volume":"55","author":"S Salman","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1128\/AAC.02595-14","article-title":"Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania","volume":"58","author":"D Mosha","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1475-2875-5-59","article-title":"Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda","volume":"5","author":"F Checchi","year":"2006","journal-title":"Malar J"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/infdis\/jiw338","article-title":"Population pharmacokinetics and pharmacodynamics of lumefantrine in young Ugandan children treated with artemether-lumefantrine for uncomplicated malaria","volume":"214","author":"E Tchaparian","year":"2016","journal-title":"J Infect Dis"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/AAC.01605-15","article-title":"Artemether-lumefantrine pharmacokinetics and clinical response are minimally altered in pregnant Ugandan women treated for uncomplicated falciparum malaria","volume":"60","author":"MM Nyunt","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-3156.2006.01785.x","article-title":"Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria","volume":"12","author":"EA Ashley","year":"2007","journal-title":"Trop Med Int Health"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-3156.2006.01784.x","article-title":"How much fat is necessary to optimize lumefantrine oral bioavailability?","volume":"12","author":"EA Ashley","year":"2007","journal-title":"Trop Med Int Health"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12916-015-0456-7","article-title":"Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data","volume":"13","year":"2015","journal-title":"BMC Med"},{"key":"ref17","article-title":"Pharmacology module","year":"2011"},{"key":"ref18","year":"2012"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.pt.2008.01.006","article-title":"Simplified antimalarial therapeutic monitoring: using the day-7 drug level?","volume":"24","author":"NJ White","year":"2008","journal-title":"Trends Parasitol"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00003088-199937020-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine","volume":"37","author":"NJ White","year":"1999","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0035-9203(98)90917-8","article-title":"The relationship between capillary and venous concentrations of the antimalarial drug lumefantrine (benflumetol)","volume":"92","author":"M van Vugt","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-2125.1998.00830.x","article-title":"Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients","volume":"46","author":"F Ezzet","year":"1998","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1086\/503423","article-title":"Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria","volume":"42","author":"RN Price","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"11","key":"ref24","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1128\/AAC.00252-10","article-title":"Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania","volume":"54","author":"SF Hietala","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/AAC.00679-09","article-title":"Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda","volume":"54","author":"J Mwesigwa","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"e8184","DOI":"10.1371\/journal.pone.0008184","article-title":"Residual antimalarials in malaria patients from Tanzania\u2014implications on drug efficacy assessment and spread of parasite resistance","volume":"4","author":"EM Hodel","year":"2009","journal-title":"PLoS ONE"},{"issue":"24","key":"ref27","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0804915","article-title":"A trial of combination antimalarial therapies in children from Papua New Guinea","volume":"359","author":"HA Karunajeewa","year":"2008","journal-title":"N Engl J Med"},{"issue":"9469","key":"ref28","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(05)66416-1","article-title":"Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial","volume":"365","author":"P Piola","year":"2005","journal-title":"Lancet"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S1473-3099(10)70202-4","article-title":"Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial","volume":"10","author":"P Piola","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4269\/ajtmh.1999.60.936","article-title":"Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria","volume":"60","author":"MV Vugt","year":"1999","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0035-9203(00)90082-8","article-title":"Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria","volume":"94","author":"M van Vugt","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5\u20136","key":"ref32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4269\/ajtmh.2001.64.247","article-title":"A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand","volume":"64","author":"G Lefevre","year":"2001","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/424512","article-title":"Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People\u2019s Democratic Republic","volume":"39","author":"M Mayxay","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"12","key":"ref34","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/j.1365-3156.2006.01739.x","article-title":"Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia","volume":"11","author":"MB Denis","year":"2006","journal-title":"Trop Med Int Health"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1128\/AAC.42.1.135","article-title":"Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria","volume":"42","author":"M van Vugt","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"ref36","doi-asserted-by":"crossref","first-page":"e26005","DOI":"10.1371\/journal.pone.0026005","article-title":"Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast","volume":"6","author":"S Borrmann","year":"2011","journal-title":"PLoS ONE"},{"issue":"9","key":"ref37","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/AAC.01115-10","article-title":"Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria","volume":"55","author":"AA Djimde","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1475-2875-12-250","article-title":"Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia","volume":"12","author":"B Schramm","year":"2013","journal-title":"Malar J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/1475-2875-12-251","article-title":"Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial","volume":"12","author":"B Schramm","year":"2013","journal-title":"Malar J"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/infdis\/jiq001","article-title":"Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial","volume":"203","author":"J Ursing","year":"2011","journal-title":"J Infect Dis"},{"issue":"7","key":"ref41","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/cid\/cir066","article-title":"Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children &lt;5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial","volume":"52","author":"BE Ngasala","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1475-2875-10-64","article-title":"Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study","volume":"10","author":"BE Ngasala","year":"2011","journal-title":"Malar J"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1086\/599378","article-title":"Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial","volume":"200","author":"JF Faucher","year":"2009","journal-title":"J Infect Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1475-2875-7-149","article-title":"The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria","volume":"7","author":"SJ Lee","year":"2008","journal-title":"Malar J"},{"key":"ref45","year":"2006"},{"issue":"6","key":"ref46","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S1473-3099(15)70024-1","article-title":"The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data","volume":"15","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/1475-2875-9-253","article-title":"Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects","volume":"9","author":"S Abdulla","year":"2010","journal-title":"Malar J"},{"issue":"10","key":"ref48","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1128\/AAC.00267-15","article-title":"Lumefantrine and desbutyl-lumefantrine population pharmacokinetic-pharmacodynamic relationships in pregnant women with uncomplicated Plasmodium falciparum malaria on the Thailand-Myanmar border","volume":"59","author":"F Kloprogge","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"ref49","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/jphp.12795","article-title":"Improved pharmacokinetic and pharmacodynamic attributes of artemether-lumefantrine-loaded solid SMEDDS for oral administration","volume":"201769","author":"S Bhandari","journal-title":"J Pharm Pharmacol"},{"issue":"9","key":"ref50","first-page":"e00868","article-title":"Bioavailability of lumefantrine is significantly enhanced with a novel formulation approach, an outcome from a randomized, open-label pharmacokinetic study in healthy volunteers","volume":"61","author":"JP Jain","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12916-016-0716-1","article-title":"Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and Niger","volume":"14","author":"L Denoeud-Ndam","year":"2016","journal-title":"BMC Med"},{"issue":"10","key":"ref52","doi-asserted-by":"crossref","first-page":"e0186589","DOI":"10.1371\/journal.pone.0186589","article-title":"Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children","volume":"12","author":"L Huang","year":"2017","journal-title":"PLoS ONE"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12936-017-1914-9","article-title":"Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women","volume":"16","author":"RF Mutagonda","year":"2017","journal-title":"Malar J"},{"issue":"3","key":"ref54","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/cid\/ciw291","article-title":"Antiretroviral choice for HIV impacts antimalarial exposure and treatment outcomes in Ugandan children","volume":"63","author":"S Parikh","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T06:41:14Z","timestamp":1571467274000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002579"}},"subtitle":[],"editor":[{"given":"James G.","family":"Beeson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,6,12]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002579","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,12]]}}}